𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The probability of death score: A measure of injury severity for use in planning and evaluating accident prevention

✍ Scribed by Ronald L. Somers

Publisher
Elsevier Science
Year
1983
Tongue
English
Weight
786 KB
Volume
15
Category
Article
ISSN
0001-4575

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Disease Activity Score is not suitab
The Disease Activity Score is not suitable as the sole criterion for initiation and evaluation of anti–tumor necrosis factor therapy in the clinic: Discordance between assessment measures and limitations in questionnaire use for regulatory purposes
✍ Frederick Wolfe; Kaleb Michaud; Theodore Pincus; Daniel Furst; Edward Keystone 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 218 KB 👁 2 views

## Abstract ## Objective The Disease Activity Score (DAS) is widely used in clinical trials. A DAS of 5.1 defines the level of severe rheumatoid arthritis (RA) and is the criterion for the initiation of anti–tumor necrosis factor therapy in the UK and The Netherlands. In North America, similar rul

Evaluating the serial use of the myelofi
Evaluating the serial use of the myelofibrosis symptom assessment form for measuring symptomatic improvement : Performance in 87 myelofibrosis patients on a JAK1 and JAK2 inhibitor (INCB018424) clinical trial
✍ Ruben A. Mesa; Hagop Kantarjian; Ayalew Tefferi; Amylou Dueck; Richard Levy; Kri 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 264 KB 👁 1 views

## Abstract ## BACKGROUND: Symptomatic burden from constitutional symptoms, anemia, and splenomegaly‐related symptoms are common and morbidity inducing in patients with myelofibrosis (MF). The authors previously developed a MF‐specific instrument for capturing the burden of MF‐associated disease‐r

The Production of oil of American Wormse
The Production of oil of American Wormseed, U. S. P., in Illinois**This investigation was undertaken because the supply of wormseed oil has been for several years vcry inadequate to the demand, and this condition has prevented extensive use of the oil in the treatment of domestic animals—a field in which it is much needed. Owing to the low individual value of such animals as hogs, for example, it is not economical to treat them with a drug of such high price as wormseed oil. This paper is a report of the first year’s work in producing this oil at the Experiment Station of the Moorman Mfg. Co., Quincy, Ill. It is planned to continue the work on a much larger scale, covering every phase of the problem. Anyone wishing to produce the oil can obtain the full cooperation of this company on request.
✍ Konantz, W.A. 📂 Article 📅 1924 🏛 Elsevier ⚖ 408 KB 👁 2 views